Publicly funded clinical drug trials. The current system of financing research through government imposed patent monopolies is incredibly inefficient. As a result, drugs that would be cheap in a free market sell at outrageous prices. This vast gap between the patent-protected price and the production costs encourage corruption. If the government paid for the clinical trials (buying rights to promising compounds) all new drugs could be sold at generic prices.